trial · primary record
XS-02 capsules
Solid Tumor
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 96 |
| Primary completion | 2029-11-13 |
| Primary endpoint | Occurrence of Dose Limiting Toxicity (DLT) (DLT observation period).(phase Ia) |
| Registry ID | NCT06531486 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:37.266Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06531486
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.